Annual CFF
$237.30 M
-$23.74 M-9.09%
December 31, 2023
Summary
- As of February 7, 2025, ZNTL annual cash flow from financing activities is $237.30 million, with the most recent change of -$23.74 million (-9.09%) on December 31, 2023.
- During the last 3 years, ZNTL annual CFF has fallen by -$123.14 million (-34.16%).
- ZNTL annual CFF is now -34.16% below its all-time high of $360.44 million, reached on December 31, 2020.
Performance
ZNTL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$92.00 K
+$83.00 K+922.22%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL quarterly cash flow from financing activities is $92.00 thousand, with the most recent change of +$83.00 thousand (+922.22%) on September 30, 2024.
- Over the past year, ZNTL quarterly CFF has dropped by -$217.00 thousand (-70.23%).
- ZNTL quarterly CFF is now -99.96% below its all-time high of $236.62 million, reached on June 30, 2023.
Performance
ZNTL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$108.00 K
-$217.00 K-66.77%
September 30, 2024
Summary
- As of February 7, 2025, ZNTL TTM cash flow from financing activities is $108.00 thousand, with the most recent change of -$217.00 thousand (-66.77%) on September 30, 2024.
- Over the past year, ZNTL TTM CFF has dropped by -$286.94 million (-99.96%).
- ZNTL TTM CFF is now -99.97% below its all-time high of $389.55 million, reached on June 30, 2022.
Performance
ZNTL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ZNTL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.1% | -70.2% | -100.0% |
| 3 y3 years | -34.2% | -70.2% | -100.0% |
| 5 y5 years | +2405.3% | -70.2% | -100.0% |
ZNTL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -9.1% | +32.9% | -100.0% | -100.0% | -100.0% | at low |
| 5 y | 5-year | -34.2% | +190.0% | -100.0% | +115.5% | -100.0% | at low |
| alltime | all time | -34.2% | +2405.3% | -100.0% | +115.5% | -100.0% | -100.0% |
Zentalis Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $92.00 K(+922.2%) | $108.00 K(-66.8%) |
| Jun 2024 | - | $9000.00(+28.6%) | $325.00 K(-99.9%) |
| Mar 2024 | - | $7000.00(>+9900.0%) | $236.94 M(-0.2%) |
| Dec 2023 | $237.30 M(-9.1%) | $0.00(-100.0%) | $237.30 M(-17.3%) |
| Sep 2023 | - | $309.00 K(-99.9%) | $287.04 M(-0.1%) |
| Jun 2023 | - | $236.62 M(>+9900.0%) | $287.32 M(+10.4%) |
| Mar 2023 | - | $373.00 K(-99.3%) | $260.16 M(-0.3%) |
| Dec 2022 | $261.04 M(+46.2%) | $49.74 M(+8345.0%) | $261.04 M(+16.8%) |
| Sep 2022 | - | $589.00 K(-99.7%) | $223.57 M(-42.6%) |
| Jun 2022 | - | $209.46 M(>+9900.0%) | $389.55 M(+116.7%) |
| Mar 2022 | - | $1.26 M(-89.7%) | $179.78 M(+0.7%) |
| Dec 2021 | $178.52 M | $12.27 M(-92.6%) | $178.52 M(+7.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $166.57 M(<-9900.0%) | $165.66 M(+6.9%) |
| Jun 2021 | - | -$316.00 K(<-9900.0%) | $154.99 M(-55.3%) |
| Mar 2021 | - | $0.00(-100.0%) | $346.96 M(-3.7%) |
| Dec 2020 | $360.44 M(+340.5%) | -$594.00 K(-100.4%) | $360.44 M(-0.1%) |
| Sep 2020 | - | $155.90 M(-18.7%) | $360.98 M(+25.8%) |
| Jun 2020 | - | $191.66 M(+1322.4%) | $286.96 M(+201.1%) |
| Mar 2020 | - | $13.47 M(<-9900.0%) | $95.30 M(+16.5%) |
| Dec 2019 | $81.83 M(+763.9%) | -$53.00 K(-100.1%) | $81.83 M(-0.1%) |
| Sep 2019 | - | $81.88 M(>+9900.0%) | $81.88 M(>+9900.0%) |
| Jun 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2019 | - | $0.00 | $0.00 |
| Dec 2018 | $9.47 M | - | - |
FAQ
- What is Zentalis Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals annual CFF year-on-year change?
- What is Zentalis Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals quarterly CFF year-on-year change?
- What is Zentalis Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Zentalis Pharmaceuticals?
- What is Zentalis Pharmaceuticals TTM CFF year-on-year change?
What is Zentalis Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of ZNTL is $237.30 M
What is the all time high annual CFF for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high annual cash flow from financing activities is $360.44 M
What is Zentalis Pharmaceuticals annual CFF year-on-year change?
Over the past year, ZNTL annual cash flow from financing activities has changed by -$23.74 M (-9.09%)
What is Zentalis Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of ZNTL is $92.00 K
What is the all time high quarterly CFF for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high quarterly cash flow from financing activities is $236.62 M
What is Zentalis Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, ZNTL quarterly cash flow from financing activities has changed by -$217.00 K (-70.23%)
What is Zentalis Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of ZNTL is $108.00 K
What is the all time high TTM CFF for Zentalis Pharmaceuticals?
Zentalis Pharmaceuticals all-time high TTM cash flow from financing activities is $389.55 M
What is Zentalis Pharmaceuticals TTM CFF year-on-year change?
Over the past year, ZNTL TTM cash flow from financing activities has changed by -$286.94 M (-99.96%)